Skip to search formSkip to main contentSkip to account menu

antihemophilic factor, porcine B-domain truncated recombinant 1 UNT Injection [Obizur]

Known as: ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT 500 [USP'U] in 3 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [OBIZUR], OBIZUR KIT, Obizur 1 UNT Injection 
National Institutes of Health

Related topics

Related topics

10 relations
Calcium ChlorideInjectionObizurPolysorbate 80

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®).
2020
2020
Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience.
BACKGROUND In 2016, a new recombinant B-domain deleted porcine FVIII (rpFVIII) was licensed in Italy for the treatment of… 
2019
2019
Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII
Acquired hemophilia A (AHA) is a rare autoimmune disorder caused by autoantibodies against Factor VIII (FVIII). It has a high… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)